Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Clinical trial NCT01815736 · COMPLETED
Trial details
- NCT number
- NCT01815736
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-27
- Primary completion
- 2015-03-16
- Enrollment
- 1443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.